CD4+ T Cells Play Distinct Roles during the Priming versus Effector Phases of Immune Checkpoint Therapy–Dependent Tumor Elimination by CD8+ T Cells - Samuel Ameh; Derek J. Theisen; Mahima Thapa; Jackson S. Turner; Abhinav Rangarajan; Christopher A. Nelson; Aaron J. Schmitz; Yuang Song; Ruan F. Vieira Medrano; Cora D. Arthur; J. Michael White; Kathleen C.F. Sheehan; et al. (Cancer Immunology Research, 2026)